Details of the Drug

General Information of Drug (ID: DMOUGX1)

Drug Name
Diamyd
Synonyms
Oramyd; Human glutamate decarboxylase 65 kDa isoform; RhGAD-65; GAD65 (diabetes), Biosyn; GAD65 (diabetes), Diamyd; GAD65 (diabetes), OMJPI; GAD65 antigen-based therapy (diabetes), Johnson and Johnson; GAD65 (diabetes), Ortho-McNeil-Janssen Pharmaceuticals
Indication
Disease Entry ICD 11 Status REF
Type-1 diabetes 5A10 Phase 3 [1]
Affected Organisms
Humans and other mammals
Cross-matching ID
UNII
I7YY5T4995
DrugBank ID
DB04963
TTD ID
D01KNA
Combinatorial Drugs (CBD) Click to Jump to the Detailed CBD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Glutamate decarboxylase 2 (GAD2) TT7UY6K DCE2_HUMAN Immunomodulator [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT00751842) A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Diamyd Medical.